Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07312136) titled 'MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study' on Dec. 16, 2025.
Study Type: Observational
Primary Sponsor: Linkoeping University
Condition:
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Cirrhosis
Advanced Fibrosis
Sarcopenia
Obesity & Overweight
Type 2 Diabetes
Hypertension
OSAS (Obstructive Sleep Apneas Syndrome)
Metabolic Syndrome
Recruitment Status: Recruiting
Date of First Enrollment: December 16, 2025
Target Sample Size: 317
Countries of Recruitment:
Sweden
To know more, visit https://clinicaltrials.gov/study/NCT07312136
Disclaimer: Curated by HT Syndication....